SEC Comment Letter for GSK (GSK) — Mar 2, 2009

GSK plc
Date: March 2, 2009 · CIK: 0001131399 · Accession: 0000000000-09-010748

View on Edgar

AI Filing Summary & Sentiment

Date

February 26, 2009

Author

Gus Rodriguez Accounting Branch Chief

Form

UPLOAD

Company

GSK plc

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 February 26, 2009 Mr. Julian Heslop Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, Middlesex TW8 9GS England Re: GlaxoSmithKline plc Form 20-F for Fiscal Year Ended December 31, 2007 File No. 1-15170

Dear Mr. Heslop:

We have completed our review of your Form 20-F and have no further comments at this time.

Sincerely,
Gus Rodriguez Accounting Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 6010                                                                                                   February 26, 2009  Mr. Julian Heslop Chief Financial Officer GlaxoSmithKline plc  980 Great West Road Brentford, Middlesex TW8 9GS England
Re: GlaxoSmithKline plc  Form 20-F for Fiscal Year Ended December 31, 2007
File No. 1-15170

Dear Mr. Heslop:

We have completed our review of your Form 20-F and have no further comments
at this time.

Sincerely,

  Gus Rodriguez Accounting Branch Chief

SecProbe.io